摘要:
17.beta.-Acyl-4-aza-5.alpha.-androst-1-in-3-ones of the formula: ##STR1## wherein R is selected from hydrogen, methyl and ethyl R.sup.2 is methoxy, a monovalent radical selected from straight and branched chain alkyl of from 1-12 carbons, or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halo (Cl or Br) substituents, aralkyl selected from benzyl and phenethyl and heterocyclic selected from 2- or 4-pyridyl, 2-pyrrolyl, 2-furyl or thiophenyl; and R', R" and R'" are each selected from hydrogen and methyl and pharmaceutical formulations of the above compounds are active as testosterone 5.alpha.-reductase inhibitors and thus are useful for treatment of acne, seborrhea, female hirsutism, and benign prostatic hypertrophy.
摘要:
A process for dehydrogenating a compound of the formula ##STR1## which comprises reacting the compound with a silylating agent in the presence of a quinone to introduce a .DELTA..sup.1 double bond.
摘要:
Disclosed is a new process for making 17-beta branched alkanoyl-3-oxo-4-aza-5-.alpha.-androst-1-enes, agents for treating benign prostatic hypertrophy (BPH), by reacting methyl 3-oxo-4-aza-5-.alpha.-androst-1-ene-17-beta carboxylate with isobutylmagnesium bromide in the novel presence of the hexamethyldisilazane (HMDS). Use of the HMDS results in higher yield and less by-products as opposed to the standard Grignard reaction in the absence of HMDS.
摘要:
Invented are carboxyl and carboxyl alkyl ester substituted 7-keto and hydroxy analogues of synthetic steroidal compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds to inhibit steroid 5-.alpha.-reductase. Also invented are methods for preparing these compounds.
摘要:
A compound represented by the following formula ##STR1## wherein A represents a hydrogen atom or a lower alkanoyl group, Z represents an oxygen atom or the group ##STR2## in which R represents a hydrogen atom or a lower alkyl group, and X represents a halogen atom, the compound being useful for controlling androgen-dependent diseases, particularly for preventing abortion or for contraception.
摘要:
Invented are 4-aza-5-alpha-8(14)-17 substituted-androsten-3-ones having an 8(14), 7(8), or 16(17) double bond, optionally also having a 1(2) double bond, pharmaceutical compositions containing the compounds, and methods of using these compounds to inhibit steroid 5-alpha-reductase.
摘要:
The preparation of 7-aza-6-alkoxy-1-tetralones which originates with dihydroresorcinol is disclosed herein. The subject compounds are useful intermediates in the synthesis of various compounds which possess valuable pharmacological properties.
摘要:
Derivatives of the 3-keto-2-oxaandrostane family are appropriately reacted to yield 3-alkoxy-2-azaestratrienes and intermediates thereto, which compounds display valuable pharmacological e.g. anti-viral, anti-leukemic and lipidmobilizing, properties.
WHEREIN A AND B EACH REPRESENT HYDROGEN, C IS HYDROXY GROUP, ESTER OR ETHER, D, E AND F EACH REPRESENT HYDROGEN ATOM, G IS A METHYL GROUP IF THE COMPOUNDS ARE OF ANDROSTANE TYPE,OR A AND B, D AND E AND F AND G EACH REPRESENT TERMINI OF DOUBLE BOND, OR C AND D REPRESENT TOGETHER AN OXO-GROUP, ESPECIALLY A KETAL GROUP, AND X REPRESENTS CHLORINE, BROMINE, HYDROXY OR ACYLOXY A SUBSTITUTED, SECONDARY OR TERTIARY AMINO.
摘要:
THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF CHOLESTANE DERIVATIVES WITH A NITROGEN ATOM IN 2 TO 3 POSITION, HAVING THE ENERAL FORMULA
CHOLESTANE WHERE C2 IS A AND C3 IS B
WHEREIN A AND B STAND FOR A CARBONYL, METHYLENE OR IMINO OR N-METHYLIMINO GROUP, WITH THE RESTRICTION, THAT WITHIN ONE COMPOUND A AND B ARE DIFFERENT, BUT EITHER A OR B STANDS FOR AN IMINO OR N-METHYLIMINO GROUP IN EACH CASE.